Search Results - "Shimoyama, Masanori"

VCAP-AMP-VECP Compared With Biweekly CHOP for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study JCOG9801 by TSUKASAKI, Kunihiro, UTSUNOMIYA, Atae, TAMURA, Kazuo, SANO, Masayuki, MOMITA, Saburo, YAMAGUCHI, Kazunari, KAWANO, Fumio, HANADA, Shuichi, TOBINAI, Kensei, SHIMOYAMA, Masanori, HOTTA, Tomomitsu, TOMONAGA, Masao, FUKUDA, Haruhiko, SHIBATA, Taro, FUKUSHIMA, Takuya, TAKATSUKA, Yoshifusa, IKEDA, Shuichi, MASUDA, Masato, NAGOSHI, Haruhisa, UEDA, Ryuzo

“…Our previous phase II trial for treating human T-lymphotropic virus type I-associated adult T-cell leukemia-lymphoma (ATLL) with vincristine, cyclophosphamide,…”
Get full text

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A by Kinoshita, Tomohiro, Watanabe, Takashi, Itoh, Kuniaki, Yoshimura, Kenichi, Tobinai, Kensei, Ogura, Michinori, Yamaguchi, Motoko, Kurosawa, Mitsutoshi, Imaizumi, Yoshitaka, Ota, Shuichi, Kaba, Harumi, Mukai, Kiyoshi, Nakamura, Shigeo, Ohshima, Koichi, Hotta, Tomomitsu, Tsukasaki, Kunihiro, Nagai, Hirokazu, Shimoyama, Masanori

“…The clinical characteristics of B-cell lymphoma (BCL) were studied through the combined analysis of six clinical trials conducted by the Japan Clinical…”
Get full text

Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents by Takahashi, Hideaki, Ikeda, Masafumi, Kumada, Takashi, Osaki, Yukio, Kondo, Shunsuke, Kusumoto, Shigeru, Ohkawa, Kazuyoshi, Nadano, Seijin, Furuse, Junji, Kudo, Masatoshi, Ito, Kiyoaki, Yokoyama, Masahiro, Okusaka, Takuji, Shimoyama, Masanori, Mizokami, Masashi

“…Aim The purpose of this multicenter cooperative study was to elucidate the clinical features of hepatitis B virus (HBV) reactivation by chemotherapeutic agents…”
Get full text

STX11 functions as a novel tumor suppressor gene in peripheral T‐cell lymphomas by Yoshida, Noriaki, Tsuzuki, Shinobu, Karube, Kennosuke, Takahara, Taishi, Suguro, Miyuki, Miyoshi, Hiroaki, Nishikori, Momoko, Shimoyama, Masanori, Tsukasaki, Kunihiro, Ohshima, Koichi, Seto, Masao

“…Peripheral T‐cell lymphomas (PTCL) are a heterogeneous group of non‐Hodgkin lymphomas with poor prognosis. Their molecular pathogenesis has not been entirely…”
Get full text

Lymphoma Study Group of JCOG by Tsukasaki, Kunihiro, Tobinai, Kensei, Hotta, Tomomitu, Shimoyama, Masanori

“…The Lymphoma Study Group (LSG) of the Japan Clinical Oncology Group (JCOG) was initiated in 1978 by five institutions and now has 47 members. JCOG-LSG has…”
Get full text

Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma by Tsukasaki, Kunihiro, Imaizumi, Yositaka, Tokura, Yoshiki, Ohshima, Kouichi, Kawai, Kazuhiro, Utsunomiya, Atae, Amano, Masahiro, Watanabe, Toshiki, Nakamura, Shigeo, Iwatsuki, Keiji, Kamihira, Shimeru, Yamaguchi, Kazunari, Shimoyama, Masanori

“…Based on the advances in research on the clinicopathophysiology of adult T‐cell leukemia‐lymphoma (ATL), Japanese researchers collected and evaluated cases of…”
Get full text

Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305) by Ogura, Michinori, Itoh, Kuniaki, Kinoshita, Tomohiro, Fukuda, Haruhiko, Takenaka, Takeaki, Ohtsu, Tomoko, Kagami, Yoshitoyo, Tobinai, Kensei, Okamoto, Masataka, Asaoku, Hideki, Sasaki, Tsuneo, Mikuni, Chikara, Hirano, Masami, Chou, Takaaki, Ohnishi, Kazunori, Ohno, Hitoshi, Nasu, Kaori, Okabe, Kenichi, Ikeda, Shuichi, Nakamura, Shigeo, Hotta, Tomomitsu, Shimoyama, Masanori

“…Although ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) therapy has been regarded as a standard of care for advanced-stage Hodgkin lymphoma (HL)…”
Get full text

Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan by Itoh, Kuniaki, Kinoshita, Tomohiro, Watanabe, Takashi, Yoshimura, Kenichi, Okamoto, Rumiko, Chou, Takaaki, Ogura, Michinori, Hirano, Masami, Asaoku, Hideki, Kurosawa, Mitsutoshi, Maeda, Yoshiharu, Omachi, Ken, Moriuchi, Yukiyoshi, Kasai, Masaharu, Ohnishi, Kazunori, Takayama, Nobuyuki, Morishima, Yasuo, Tobinai, Kensei, Kaba, Harumi, Yamamoto, Seiichiro, Fukuda, Haruhiko, Kikuchi, Masahiro, Yoshino, Tadashi, Matsuno, Yoshihiro, Hotta, Tomomitsu, Shimoyama, Masanori

“…The Japan Clinical Oncology Group conducted two multicenter phase II trials in 200 patients with advanced Hodgkin lymphoma (HL) in the 1990s. Among 181…”
Get full text

Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508 by Kagami, Yoshitoyo, Itoh, Kuniaki, Tobinai, Kensei, Fukuda, Haruhiko, Mukai, Kiyoshi, Chou, Takaaki, Mikuni, Chikara, Kinoshita, Tomohiro, Fukushima, Noriyasu, Kiyama, Yoshio, Suzuki, Takayo, Sasaki, Tsuneo, Watanabe, Yuko, Tsukasaki, Kunihiro, Hotta, Tomomitsu, Shimoyama, Masanori, Ogura, Michinori

“…The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisolone, known as CHOP therapy, has been established as the standard treatment for…”
Get full text

Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705) by Ogura, Michinori, Itoh, Kuniaki, Ishizawa, Kenichi, Kobayashi, Yukio, Tobinai, Kensei, Kinoshita, Tomohiro, Hirano, Masami, Ueda, Ryuzo, Shibata, Taro, Nakamura, Shigeo, Tsukasaki, Kunihiro, Hotta, Tomomitsu, Shimoyama, Masanori, Morishima, Yasuo

“…The role of dacarbazine in ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) therapy in Hodgkin lymphoma (HL) remains unclear. This phase II study…”
Get full text

Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004 by Tobinai, Kensei, Takeyama, Kunihiko, Arima, Fumito, Aikawa, Keiko, Kobayashi, Tohru, Hanada, Shuichi, Kasai, Masaharu, Ogura, Michinori, Sueoka, Eisaburo, Mukai, Kiyoshi, Tajima, Kinuko, Fukuda, Haruhiko, Shirakawa, Shigeru, Hotta, Tomomitsu, Masanori, Shimoyama

“…Granulocyte colony‐stimulating factor (G‐CSF)‐supported, post‐remission chemotherapy (Cx) for adult acute lymphoblastic leukemia (ALL) or lymphoblastic…”
Get full text

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109) by TSUKASAKI, Kunihiro, TOBINAI, Kensei, TARA, Mitsutoshi, MIKUNI, Chikara, HOTTA, Tomomitsu, SHIMOYAMA, Masanori, KOZURU, Mitsuo, UIKE, Naokuni, YAMADA, Yasuaki, TOMONAGA, Masao, ARAKI, Koichi, KASAI, Masaharu, TAKATSUKI, Kiyoshi

“…Aggressive adult T-cell leukemia-lymphoma (ATL) generally has a very poor prognosis. Deoxycoformycin (DCF, pentostatin), an inhibitor of adenosine deaminase,…”
Get full text

The status of antithymocyte globulin therapy for adult patients in Japan: retrospective analysis of a nationwide survey by Hattori, Mamiko, Terasawa, Teruhiko, Tsushita, Keitaro, Utsumi, Makoto, Kawano, Fumio, Saito, Hidehiko, Shimoyama, Masanori, Ohashi, Haruhiko

“…We conducted a nationwide survey on antithymocyte globulin (ATG) therapy for adult patients in Japan. We mailed questionnaires to 454 hospitals with hematology…”
Get full text

A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002 by KINOSHITA, Tomohiro, HOTTA, Tomomitsu, MIKUNI, Chikara, TOKI, Hironobu, SANO, Masayuki, MASAKI, Yasufumi, OHTSU, Tomoko, MATSUNO, Yoshihiro, TAKENAKA, Takeaki, SHIRAKAWA, Shigeru, SHIMOYAMA, Masanori, TOBINAI, Kensei, KOBAYASHI, Tohru, ISHIZUKA, Naoki, TOMONAGA, Masao, SAI, Toshiaki, OHNO, Youichiro, KASAI, Masaharu, OGURA, Michinori

“…The effect of enhancing the dose intensity (DI) of the key drugs in multidrug combination chemotherapy for malignant lymphoma is uncertain. We investigated the…”
Get full text

A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients : Japan clinical oncology group study JCOG9203 by MIZOROKI, Fumi, HIROSE, Yuko, FUKUHARA, Shiro, NASU, Kaori, OHNO, Yoichiro, TOKI, Hironobu, TOGAWA, Atsushi, KIKUCHI, Masahiro, HOTTA, Tomomitsu, SHIMOYAMA, Masanori, SANO, Masayuki, FUKUDA, Haruhiko, TOBINAI, Kensei, NAKATA, Masanobu, TANIWAKI, Masafumi, KAWANO, Fumio, UOZUMI, Kimiharu, SAWADA, Kenichi

“…The Lymphoma Study Group (LSG) of the Japan Clinical Oncology Group conducted a phase II trial of LSG12 therapy for 45 elderly patients with aggressive…”
Get full text

Failure to detect Epstein-Barr virus (EBV) DNA in plasma by real-time PCR in a case of EBV-associated posttransplantation lymphoproliferative disorder confined to the central nervous system by TERASAWA, Teruhiko, OHASHI, Haruhiko, TSUSHITA, Keitaro, UTSUMI, Makoto, MUKAI, Eiichiro, NAKAMURA, Shigeo, SHIMOYAMA, Masanori

“…We report here a patient who developed multiple central nervous system (CNS) space-occupying lesions 6 months after bone marrow transplantation from an…”
Get full text

Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0 by SUZUKI, Ritsuro, MURATA, Makoto, MATSUDA, Shin, HIRAI, Hisamaru, YORIMITSU, Seiichi, HAMAJIMA, Nobuyuki, SETO, Masao, SHIMOYAMA, Masanori, OHNO, Ryuzo, MORISHIMA, Yasuo, NAKAMURA, Shigeo, KAMI, Masahiro, OHTAKE, Shigeki, ASOU, Norio, KODERA, Yoshihisa, TOMONAGA, Masao, MASAKI, Yasufumi, KUSUMOTO, Shuya, TAKEUCHI, Jin

“…Myeloid/natural killer (NK) cell precursor acute leukemia is an entity of acute leukemia characterized by poor prognosis and a CD7+CD56+ myeloid antigen+…”
Get full text

History of research on malignant lymphoma by Shimoyama, Masanori

Get full text

Phase iii Study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: A Japan Clinical Oncology Group Study, JCOG 9301 by TAKENAKA, Takeaki, ITOH, Kuniaki, MIKUNI, Chikara, DEURA, Kijoh, YAMADA, Takashi, MIZOROGI, Fumi, NAGOSHI, Haruhisa, TOMONAGA, Masao, HOTTA, Tomomitsu, KAWANO, Kohichi, TSUSHITA, Keitaro, HIRANO, Masami, SUZUKI, Takayo, SHIMOYAMA, Masanori, UTSUNOMIYA, Atae, MATSUDA, Shin, CHOU, Takaaki, SAI, Toshiaki, SANO, Masayuki, KONDA, Susumu, OHNO, Tatsuji

“…To investigate whether combination chemotherapy with vincristine, cyclophosphamide, prednisolone, and melphalan (COP/ MP) with the addition of ranimustine…”
Get full text

Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors by Takeyama, K, Seto, M, Uike, N, Hamajima, N, Ino, T, Mikuni, C, Kobayashi, T, Maruta, A, Muto, Y, Maseki, N, Sakamaki, H, Saitoh, H, Shimoyama, M, Ueda, R

“…It is known that alkylating agents and topoisomerase II inhibitors can cause distinct forms of therapy-related leukemia and myelodysplastic syndrome (TRL/MDS)…”
Get more information